Alpha2-HS glycoprotein: A protein in search of a function

Diabetes/Metabolism Research and Reviews

Volumn 18, Issue 4, 2002, Pages 311-314

  Arnaud, Philippe ^a   Kalabay, Laszlo ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Alpha2 HS glycoprotein; Biologic function; Glucose metabolism; Protease inhibitor; Tyrosine kinase inhibitor

Indexed keywords

ALPHA2 HEREMANS SCHMID GLYCOPROTEIN; GLUCOSE; PLASMA PROTEIN; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BONE DENSITY; BONE MINERALIZATION; CARDIOMYOPATHY; GLUCOSE METABOLISM; HUMAN; IMMUNOMODULATION; MEDICAL RESEARCH; MOUSE; NONHUMAN; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTEINASE INHIBITION;

ANIMALS; BLOOD PROTEINS; GLUCOSE; HEART; HUMANS; PHOSPHOTYROSINE; PROTEIN-TYROSINE KINASES; RATS;

EID: 0036657222     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.315     Document Type: Article

References (44)

1. Heremans JF (ed.). Les Globulines Seriques du Systeme Gamma. Arscia: Brussels, 1960; 103-105.
2. Schmid K, Burgi W. Preparation and properties of the human plasma Ba-alpha2 glycoprotein. Biochim Biophys Acta 1960; 17: 440-453.
3. Putnam FW. Progress in plasma proteins. In The Plasma Proteins, vol. 4. Putnam FW (ed.). Academic Press: New York, NY, 1984; 1-44.
4. Ohnishi T, Arakaki N, Nakamura O, Hirono S, Daikuhara Y. Purification, characterization, and studies on biosynthesis of a 59-kDa bone sialic acid-containing protein (BSP) from rat mandible using a monoclonal antibody. Evidence that 59-kDa BSP may be the rat counterpart of human alpha2-HS glycoprotein and is synthesized by both hepatocytes and osteoblasts. J Biol Chem 1991; 266: 14636-14645.
5. Hayase T, Rice KG, Dziegielewska KM, Kuhlenschmidt M, Lee YC. Comparison of N-glycosides of fetuins from different species and human alpha2-HS glycoprotein. Biochemistry 1992; 31: 4915-4921.
6. Gejyo F, Chang JL, Burgi W, et al. Characterization of the B-chain of human plasma alpha2-HS glycoprotein. J Biol Chem 1983; 258: 4966-4971.
7. Gejyo F, Schmid K. Purification and characterization of the two forms of human plasma alpha2-HS glycoprotein. Biochim Biophys Acta 1981; 671: 78-84.
8. Arnaud P, Mietz JA, Grossman Z, McBride OW. Isolation and characterization of a cDNA clone for human alpha2-HS glycoprotein. In Proteins in Biological Fluids, vol. 35. Peeters H (ed.). Pergamon Press: Oxford, 1987; 135-138.
9. Lee CC, Bowman BH, Yang F. Human alpha2-HS glycoprotein: the A and B chains with a connecting sequence are encoded by a single mRNA transcript. Proc Natl Acad Sci U S A 1987; 84: 4403-4407.
10. Jahnen-Dechent W, Trindl A, Godovac-Zimmermann J, Müller-Esterl W. Posttranslational processing of human alpha2-HS glycoprotein (human fetuin). Evidence for the production of a phosphorylated single-chain form by hepatoma cells. Eur J Biochem 1994; 226: 59-69.
11. Pedersen KO. Fetuin, a new globulin isolated from serum. Nature 1944; 154: 575.
12. Dziegielewska KM, Brown WM, Casey SJ, et al. The complete cDNA and amino acid sequence of bovine fetuin. Its homology with alpha2-HS glycoprotein and relation to other members of the cystatin family. J Biol Chem 1990; 265: 4354-4357.
13. Auberger P, Falquerho L, Contreres JO, et al. Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell 1989; 58: 631-640.
14. Brown WM, Dziegielewska KM, Saunders NR, Christie DL, Nawratil P, Müller-Esterl W. The nucleotide and deduced amino acid structures of sheep and pig fetuin. Common structural features of the mammalian fetuin family. Eur J Biochem 1992; 205: 321-331.
15. Terkelsen OBF, Jahnen-Dechent W, Nielsen H, et al. Rat fetuin: distribution of protein and mRNA in embryonic and neonatal tissues. Acta Embryol 1998; 197: 125-133.
16. Dziegielewska KM, Matthews N, Saunders NR, Wilkinson G. Alpha2-HS glycoprotein is expressed at high concentration in human fetal plasma and CSF. Fetal Diagn Ther 1992; 8: 22-27.
17. Dziegielewska KM, Brown WM, Deal A, Foster KA, Fry EJ, Saunders NR. The expression of fetuin in the development and maturation of the hemopoietic and immune systems. Histochem Cell Biol 1996; 106: 319-330.
18. Dziegielewska KM, Daikuhara Y, Ohnishi T, et al. Fetuin in the developing neocortex of the rat: distribution and origin. J Comp Neurol 2000; 423: 373-388.
19. Nie Z. Fetuin: its enigmatic property on growth promotion. Am J Physiol 1992; 263: C551-C562.
20. Lewis JG. Alpha2-HS glycoprotein: functional studies. PhD Thesis, University of Otago, Dunedin, New Zealand, 1983.
21. Eichner JE, Friedrich CA, Cauley JA, et al. Alpha2-HS glycoprotein phenotypes and quantitative hormone and bone measures in postmenopausal women. Calcif Tissue Int 1990; 47: 345-349.
22. Dickson IR, Gwilliam M, Arora M, et al. Lumbar vertebral and femoral neck bone mineral density are higher in postmenopausal women with the alpha2-HS glycoprotein 2 phenotype. Bone Miner 1994; 24: 181-188.
23. Price PA, Thomas GR, Pardini AW, Figueira WF, Caputo JM, Williamson MK. Discovery of a high molecular weight complex of calcium, phosphate, fetuin and matrix g-carboxyglutamic acid protein in the serum of etidronate-treated rats. J Biol Chem 2002; 277: 3926-3934.
24. Kellermann J, Haupt H, Auerswald EA, Müller-Esterl W. The arrangement of disulfide loops in human alpha-2-HS glycoprotein - similarity to the disulfide bridge structures of cystatins and kininogens. J Biol Chem 1989; 264: 14121-14128.
25. Dziegielewska KM, Brown WM. Fetuin. Springer-Verlag: Heidelberg, 1995.
26. Akhoundi C, Amiot M, Auberger P, LeCam A, Rossi B. Insulin and interleukin-1 differentially regulate pp63, an acute phase phosphoprotein in hepatoma cell line. J Biol Chem 1994; 269: 15925-15930.
27. Kalabay L, Arnaud P. The production of human recombinant alpha2-HS glycoprotein in the baculovirus vector system. In 22nd Congress of the International Society of Internal Medicine, Varro V, DeChatel R (eds). Monduzzi Editore SPA: Bologna, 1994; 613-616.
28. Srinivas PR, Goustin AS, Grunberger G. Baculoviral expression of a natural inhibitor of the human insulin receptor tyrosine kinase. Biochem Biophys Res Commun 1995; 208: 879-885.
29. Srinivas PR, Wagner AS, Reddy LV, et al. Serum alpha2-HS glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. Mol Endocrinol 1993; 7: 1445-1455.
30. Srinivas PR, Deutsch DD, Mathews ST, Goustin AS, Leon MA, Grunberger G. Recombinant human alpha2-HS glycoprotein inhibits insulin-stimulated mitogenic pathway without affecting metabolic signalling in Chinese hamster ovary cells overexpressing the human insulin receptor. Cell Signal 1996; 8: 567-573.
31. Kalabay L, Chavin K, Lebreton JP, Robinson KA, Buse MG, Arnaud P. Human recombinant alpha2-HS glycoprotein is produced in insect cells as a full length inhibitor of the insulin receptor tyrosine kinase. Horm Metab Res 1998; 30: 1-6.
32. Kalabay L, Mathur S, Bobin S, Arnaud P. Electrophoretic and isoelectric focusing analysis of human recombinant alpha2-HS glycoprotein produced in insect cells: analysis of the post-translational events. Electrophoresis 1996; 17: 529-532.
33. Mathews ST, Chellam N, Srinivas PR, et al. Alpha2-HSg, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol Cell Endocrinol 2000; 164: 87-98.
34. Lin X, Braymer HD, Bray GA, York DA. Differential expression of insulin receptor tyrosine kinase inhibitor (fetuin) gene in a model of diet-induced obesity. Life Sci 1998; 63: 145-153.
35. Lebreton JP, Joisel F, Raoult JP, Lannuzel B, Rogez JP, Humbert G. Serum concentration of human alpha2-HS glycoprotein during the inflammatory process. Evidence that alpha2-HS glycoprotein is a negative acute-phase reactant. J Clin Invest 1979; 64: 1118-1129.
36. Daveau M, Davrinche C, Julen N, Hiron M, Arnaud P, Lebreton JP. The synthesis of human Alpha2-HS glycoprotein is down-regulated by cytokines in hepatoma Hep G2 cells. FEBS Lett 1988; 241: 191-194.
37. Daveau M, Davrinche C, Djelassi N, et al. Partial hepatectomy and mediators of inflammation decrease the expression of liver alpha-2-HS glycoprotein gene in rats. FEBS Lett 1990; 273: 79-81.
38. Anderson NL, Anderson NG. Microheterogeneity of serum transferrin, haptoglobin and alpha2-HS glycoprotein examined by high resolution two-dimensional electrophoresis. Biochem Biophys Res Commun 1979; 88: 258-265.
39. Boutin B, Feng SH, Arnaud P. The genetic polymorphism of alpha2-HS glycoprotein: study by ultrathin layer isoelectric focusing and immunoblot. Am J Hum Genet 1985; 37: 1098-1105.
40. Arnaud P, Miribel L, Roux AF. Alpha2-HS glycoprotein. In Methods in Enzymoloy, Immunochemical Techniques, Part H: Acute-phase Reactants, vol. 163. Sabato GD (ed.). Academic Press: London, 1988; 431-441.
41. Osawa M, Umetsu K, Ohki T, Nagasawa T, Suzuki T, Takeichi S. Molecular evidence for human alpha2-HS glycoprotein (AHSG) polymorphism. Hum Genet 1997; 99: 18-21.
42. Mathews ST, Srinivas PR, Leon MA, Grunberger G. Bovine fetuin is an inhibitor of insulin receptor tyrosine kinase. Life Sci 1997; 61: 1583-1592.
43. Demetriou M, Binkert C, Sukhu B, Tenenbaum HC, Dennis JW. Fetuin/alpha2-HS glycoprotein is a transforming growth-b type II receptor mimic and cytokine antagonist. J Biol Chem 1996; 271: 12755-12761.
44. White MF, Kahn CR. The insulin signaling system. J Biol Chem 1994; 269: 1-4.